Literature DB >> 728731

Clofibrate and the primary prevention of ischaemic heart disease.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728731      PMCID: PMC1608867          DOI: 10.1136/bmj.2.6152.1585

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate.

Authors:  J M THROP
Journal:  Lancet       Date:  1962-06-23       Impact factor: 79.321

2.  Reduction of serum-lipid and uric-acid levels by an orally active androsterone.

Authors:  M F OLIVER
Journal:  Lancet       Date:  1962-06-23       Impact factor: 79.321

3.  Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.

Authors:  L A Carlson; L E Böttiger
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

4.  Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.

Authors:  H A Dewar; M F Oliver
Journal:  Br Med J       Date:  1971-12-25

5.  Diet and sire effects on serum cholesterol and cholesterol absorption in infant baboons (Papio cynocephalus).

Authors:  G E Mott; C A McMahan; H C McGill
Journal:  Circ Res       Date:  1978-09       Impact factor: 17.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.